As pandemic-stressed consumers look to get better sleep, companies are delivering on ingredient demands and hoping the momentum stays when the pandemic subsides.
The Increasing Access to Biosimilars Act would direct the Department of Health and Human Services to create a shared savings demonstration program for biosimilar drugs in the Medicare program, which will help increase competition and expand access.
